These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 15273657

  • 1. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R, Mediero A, Martínez-Montero JC, Roldán-Pallarés M, Suárez-Leoz M, Vidal-Fernández P, Cortés-Valdés C, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jul 15; 10():450-7. PubMed ID: 15273657
    [Abstract] [Full Text] [Related]

  • 2. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Roldán-Pallarés M, Rollín R, Martínez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R.
    Retina; 2007 Feb 15; 27(2):222-35. PubMed ID: 17290206
    [Abstract] [Full Text] [Related]

  • 3. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar 15; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 4. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep 15; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 5. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X, Wang G, Wang Y.
    Am J Ophthalmol; 2009 Dec 15; 148(6):883-9. PubMed ID: 19837381
    [Abstract] [Full Text] [Related]

  • 6. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B, Chen S, Chaudhary V, Gonder J, Chakrabarti S.
    Curr Eye Res; 2009 Feb 15; 34(2):134-44. PubMed ID: 19219685
    [Abstract] [Full Text] [Related]

  • 7. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.
    Diabetologia; 1997 Sep 15; 40(9):1107-9. PubMed ID: 9300249
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May 15; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 9. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ.
    Am J Ophthalmol; 2004 Apr 15; 137(4):668-74. PubMed ID: 15059706
    [Abstract] [Full Text] [Related]

  • 10. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct 15; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

  • 11. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V.
    Retina; 2008 Jun 15; 28(6):817-24. PubMed ID: 18536597
    [Abstract] [Full Text] [Related]

  • 12. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF.
    Acta Ophthalmol Scand; 2007 Sep 15; 85(6):618-22. PubMed ID: 17488318
    [Abstract] [Full Text] [Related]

  • 13. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG, Nicoletti R, Ferrara N, Meli G, Reibaldi M, Reibaldi A.
    Exp Clin Endocrinol Diabetes; 2003 Jun 15; 111(4):209-14. PubMed ID: 12845559
    [Abstract] [Full Text] [Related]

  • 14. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov 15; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 15. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M, Rollín R, Mediero A, Martínez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R.
    Mol Vis; 2005 Jul 07; 11():461-71. PubMed ID: 16030497
    [Abstract] [Full Text] [Related]

  • 16. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
    Matsumoto M, Suzuma K, Maki T, Kinoshita H, Tsuiki E, Fujikawa A, Kitaoka T.
    Am J Ophthalmol; 2012 May 07; 153(5):896-902.e1. PubMed ID: 22265145
    [Abstract] [Full Text] [Related]

  • 17. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT, Yang CM, Huang JS, Chien CT, Yang CH, Chiang YH, Shih YF.
    Ophthalmology; 2008 Apr 07; 115(4):734-737.e1. PubMed ID: 18177940
    [Abstract] [Full Text] [Related]

  • 18. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA.
    Exp Eye Res; 2006 May 07; 82(5):798-806. PubMed ID: 16324700
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat.
    Rollín R, Mediero A, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2005 Mar 18; 11():216-24. PubMed ID: 15789000
    [Abstract] [Full Text] [Related]

  • 20. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
    Sánchez MC, Luna JD, Barcelona PF, Gramajo AL, Juarez PC, Riera CM, Chiabrando GA.
    Exp Eye Res; 2007 Nov 18; 85(5):644-50. PubMed ID: 17826767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.